The Delhi High Court on Tuesday said that the country needs to invest in the future, and directed the government to come out with a policy with regard to distribution of the drug Liposomal Amphotericin-B among the patients of mucormycosis. It said that the patients who are younger and “who hold promise for our nation in the future” may have to be prioritised in distribution of the particular drug in comparison with the older generation which has lived its life.